The formulation of BSYX had treating effect on endometrial cancer and was related with FSH/PI3K/AKT/Gankyrin/HIF-α/cyclinD1 pathway, which can supply the experimental basement of its clinical usage. This evidence concerns the gene PSMD10 and endometrial cancer.